This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract valued at $24,349.43. The contract is for the delivery of Xtandi 40 mg tablets to support the medical supply needs of the Department of Defense.
DMS Pharmaceutical Group holds a $499,999,999 IDC with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This award is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal contracts across multiple product categories.
Generated 3/17/25, 9:47 AM